tiprankstipranks
20/20 Biolabs, Inc. (AIDX)
NASDAQ:AIDX
US Market
AIDX
20/20 Biolabs, Inc.
RESEARCH TOOLSreports

20/20 Biolabs, Inc. (AIDX) Financial Statements

8 Followers

20/20 Biolabs, Inc. Financial Overview

20/20 Biolabs, Inc.'s market cap is currently $6.97M. The company's EPS TTM is $-0.28; its P/E ratio is -1.20; 20/20 Biolabs, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 2.05M$ 1.75M$ 1.42M$ 11.06M$ 9.62M
Gross Profit$ 604.54K$ 360.31K$ 109.14K$ 5.12M$ 4.69M
Operating Income$ -3.33M$ -5.66M$ -6.36M$ 1.68M$ 1.94M
EBITDA$ -3.33M$ -5.53M$ -6.19M$ 1.97M$ 2.07M
Net Income$ -3.74M$ -5.55M$ -6.39M$ 2.19M$ 2.07M
Balance Sheet
Cash & Short-Term Investments$ 1.03B$ 1.78M$ 4.09M$ 8.81M$ 3.35M
Total Assets$ 4.14B$ 3.61M$ 6.37M$ 12.22M$ 10.27M
Total Debt$ 1.28B$ 1.51M$ 2.07M$ 2.41M$ 2.35M
Net Debt$ 258.04M$ -270.61K$ -2.02M$ -6.39M$ -1.00M
Total Liabilities$ 1.69B$ 2.08M$ 2.08M$ 2.84M$ 3.38M
Stockholders' Equity$ -19.23M$ 1.53M$ 4.29M$ 9.37M$ 6.89M
Cash Flow
Free Cash Flow$ -1.92B$ -2.60M$ -4.64M$ 5.54M$ -1.30M
Operating Cash Flow$ -1.92B$ -2.60M$ -4.63M$ 5.80M$ -1.07M
Investing Cash Flow$ 0.00$ 0.00$ -43.76K$ -462.55K$ -228.15K
Financing Cash Flow$ 1.16B$ 293.33K$ -45.99K$ 112.60K$ 1.19M
Currency in USD

20/20 Biolabs, Inc. Earnings and Revenue History

Income Statement >

20/20 Biolabs, Inc. Debt to Assets

Balance Sheet >

20/20 Biolabs, Inc. Cash Flow

Cash Flow >

20/20 Biolabs, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >